Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Wiest, JohannesKehrein, Josef
Saedtler, Marco
Schilling, Klaus
Cataldi, Eleonora
Sotriffer, Christoph A
Holzgrabe, Ulrike
Rasmussen, Tim
Böttcher, Bettina
Cronin-Golomb, Mark
Lehmann, Matthias
Jung, Nathalie
Windbergs, Mike
Meinel, Lorenz
Issue Date
2020-10-29
Metadata
Show full item recordAbstract
Controlling physicochemical properties of light-unresponsive drugs, by light, prima facie, a paradox approach. We expanded light control by ion pairing light-unresponsive salicylate or ibuprofen to photoswitchable azobenzene counterions, thereby reversibly controlling supramolecular structures, hence the drugs' physicochemical and kinetic properties. The resulting ion pairs photoliquefied into room-temperature ionic liquids under ultraviolet light. Aqueous solutions showed trans-cis-dependent supramolecular structures under a light with wormlike aggregates decomposing into small micelles and vice versa. Light control allowed for permeation through membranes of cis-ibuprofen ion pairs within 12 h in contrast to the trans ion pairs requiring 72 h. In conclusion, azobenzene ion-pairing expands light control of physicochemical and kinetic properties to otherwise light-unresponsive drugs.Citation
Mol Pharm. 2020 Oct 29. doi: 10.1021/acs.molpharmaceut.0c00720. Epub ahead of print.Affiliation
HIPS, Helmholtz-Institut für Pharmazeutische Forschung Saarland, Universitätscampus E8.1 66123 Saarbrücken, Germany.Publisher
American Chemical Society (ACS)Journal
Molecular pharmaceuticsPubMed ID
33118829Type
ArticleLanguage
enEISSN
1543-8392ae974a485f413a2113503eed53cd6c53
10.1021/acs.molpharmaceut.0c00720
Scopus Count
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-ShareAlike 4.0 International